Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Royalty Pharma plc Class A Ordinary Shares (RPRX)

Royalty Pharma inks up to $275M synthetic royalty deal with Denali Therapeutics for tividenofusp alfa, driving significant social media buzz and positive sentiment.

### About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma plc is a biopharmaceutical royalty company that invests in and acquires royalty interests in innovative medicines.  
Royalty Pharma plc Class A Ordinary Shares uses the ticker $RPRX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Royalty Pharma plc Class A Ordinary Shares (RPRX) trading volume is up XXXXXX% from the previous week.
- Royalty Pharma plc Class A Ordinary Shares (RPRX) social dominance is up XXX% from the previous week.
- Royalty Pharma plc Class A Ordinary Shares (RPRX) creators is up XXXXX% from the previous month.
- Royalty Pharma plc Class A Ordinary Shares (RPRX) engagements is up XXXXXX% from the previous week.
- Royalty Pharma plc Class A Ordinary Shares (RPRX) mentions is up XXXXX% from the previous month.
- Royalty Pharma plc Class A Ordinary Shares (RPRX) posts created is up XXXXX% from the previous week.
- Royalty Pharma plc Class A Ordinary Shares Price hit a 52-Week high of $XXXXX for the hour

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/close.tsv)  
The stock price is near a 52-week high, supported by positive market sentiment, recent dealmaking such as the acquisition of a royalty interest in Alnylam's AMVUTTRA, strong Q3 performance, and strategic buybacks, indicating a bullish trend.  

24-Hour: -XXXX%
7-Day: -XXXX%
30-Day: -XXXX%

1-Year High: $XXXXX on 2025-12-10  
1-Year Low: $XXXXX on 2024-12-19  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/alt_rank.tsv)  
Royalty Pharma plc Class A Ordinary Shares (RPRX) is currently AltRank #1,399 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX -XXX  
X Month: XXXXX +22  
X Months: XXXXX +1,111  
X Year: XXXXX +57  
1-Year High: XXXXX on 2025-08-11  
1-Year Low: XX on 2024-12-21  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX +6  
1-Year High: XX on 2025-01-10  
1-Year Low: X on 2025-11-25  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX +254%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX +26%  
1-Year High: XXXXXXX on 2025-02-11  
1-Year Low: XX on 2025-09-27  

Engagements by network (24h):
Reddit: XX
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX +29%  
X Month: XXX +37%  
X Months: XXXXX +25%  
X Year: XXXXX +57%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-29  

Mentions by network (24h):
Reddit: XX
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Royalty Pharma plc Class A Ordinary Shares (RPRX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX +17%  
X Month: XXX +35%  
X Months: XXXXX +91%  
X Year: XXXXX +93%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-29  

The most influential creators that mention Royalty Pharma plc Class A Ordinary Shares in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@MarketCap_Live](/creator/twitter/MarketCap_Live)   | X    | XXX       | X     | XXX         |
| [@PrismMarketView](/creator/twitter/PrismMarketView) | X    | XXXXX     | X     | XX          |
| [@Tautilas](/creator/twitter/Tautilas)               | X    | XXXXX     | X     | XX          |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X    | XXXXX     | X     | XX          |
| [@foter468560](/creator/twitter/foter468560)         | X    | X         | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | X    | XXXXX     | X     | X           |
| [@Trade_market8](/creator/twitter/Trade_market8)     | X    | XX        | X     | X           |

[View More](/list/creators/$rprx/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +35%  
X Year: XXX% +20%  
1-Year High: XXX% on 2025-03-16  
1-Year Low: XX% on 2025-09-15  

Most Supportive Themes:
- Royalty Pharma's Financial Performance and Strategy: (30%) Discussions highlight Royalty Pharma's financial guidance, including expected shareholder returns and cash flow, alongside its strategic approach to acquiring biopharmaceutical royalties.
- Biopharmaceutical Investments and Partnerships: (25%) Posts frequently mention Royalty Pharma's involvement in funding and acquiring stakes in biopharmaceutical companies and their drug royalties, indicating strategic partnerships and investment potential.
- Stock Performance and Valuations: (20%) Analysis of Royalty Pharma's stock performance, including price targets, and comparisons to other healthcare stocks, suggests a focus on its investment value.
  
Most Critical Themes:
- Valuation Comparisons and Market Sentiment: (15%) Some posts compare Royalty Pharma's valuation multiples to other sectors, suggesting potential overvaluation or a need for further justification of its current market position.
- Insider Trading and Ownership Changes: (10%) Mentions of insider trading activity, including CEO stock purchases and past ownership by notable investors, prompt scrutiny and analysis of the company's internal confidence and strategic direction.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXX%  
X Week: XXXXXX% +0.003%  
X Month: XXXX% +0.016%  
X Months: XXXX% +0.01%  
X Year: XXXX% +0.01%  
1-Year High: XXXXX% on 2025-01-25  
1-Year Low: XXXXXX% on 2025-09-29  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-03-31  
1-Year Low: XXXXX% on 2024-12-13  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rprx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$rprx/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX -$3.60%  
X Month: $XXXXXXXXXXXXXX -$1.20%  
X Months: $XXXXXXXXXXXXXX +$9.50%  
X Year: $XXXXXXXXXXXXXX +$41%  
1-Year High: $XXXXXXXXXXXXXX on 2025-03-16  
1-Year Low: $XXXXXXXXXXXXXX on 2024-12-19  

### Top Royalty Pharma plc Class A Ordinary Shares Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Buy Signal Royalty Pharma plc - X Dec 2025 @ 11:51 - USD38.30"  
[Reddit Link](https://redd.it/1picktt) [@jvc72](/creator/reddit/jvc72) 2025-12-09T17:01Z X followers, X engagements


"After Hours Largecaps ($20-200B) - Dec X Gainers Losers $ARES +7% $ALAB -XXX% $RPRX +3.4% $INSM -XXX% $CIEN +2.1% $CHKP -XXX% $CYBR +2% $STM -XXXX% $STLD +1.7% $IMO -XXXX% $RKLB +1.3% $MRVL -XXXX% $COHR +1.3% $RDDT -XXXX% $STX +0.91% $ERIC -XXXX% $SONY +0.8% $GILD -XXX% $SMCI +0.79% $SOFI -XXXX% $BHP +0.79% $CRWV -XXXX% $HCA +0.77% $VOD -XXXX% $INTC +0.69% $MCHP -XXXX% $CCI +0.69% $STZ -XXXX% $FLEX +0.68% $ORLY -0.44%"  
[X Link](https://x.com/MarketCap_Live/status/1998187404348498301) [@MarketCap_Live](/creator/x/MarketCap_Live) 2025-12-09T00:26Z XXX followers, XXX engagements


"🚀 Boost4 : Running Trades December X 🚀 XX trades open 🔥 Top performers: 🟩 $AAPL : +7.74% steady but not accelerating 🟩 $MMM : +1.75% constructive but shallow 🟩 $RPRX : +2.11% stabilizing ⚠ Weak spots: None this week. 🕓 On Hold: $UPBD mis-entered SL caused large cumulative loss; awaiting re-entry conditions $TMDX wide planned SL hit during volatility; structure still unstable New this week: $ASML $KTOS $LC $MRVL $NU $JETS 📌 Several setups finally triggered late in the week a constructive sign after prolonged market indecision. #Boost4 #TradeUpdate #TechnicalAnalysisX #Boost4"  
[X Link](https://x.com/AdiPlaut/status/1998071972912087249) [@AdiPlaut](/creator/x/AdiPlaut) 2025-12-08T16:47Z XXX followers, XX engagements


"Its not often I own a heavily shorted healthcare company also owned by $NVDA and Cathie Wood but when I do its $rprx"  
[X Link](https://x.com/Aureliusltd28/status/1998033665218203961) [@Aureliusltd28](/creator/x/Aureliusltd28) 2025-12-08T14:15Z 12.8K followers, 3950 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Royalty Pharma plc Class A Ordinary Shares (RPRX)

Royalty Pharma inks up to $275M synthetic royalty deal with Denali Therapeutics for tividenofusp alfa, driving significant social media buzz and positive sentiment.

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma plc is a biopharmaceutical royalty company that invests in and acquires royalty interests in innovative medicines.
Royalty Pharma plc Class A Ordinary Shares uses the ticker $RPRX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Royalty Pharma plc Class A Ordinary Shares (RPRX) trading volume is up XXXXXX% from the previous week.
  • Royalty Pharma plc Class A Ordinary Shares (RPRX) social dominance is up XXX% from the previous week.
  • Royalty Pharma plc Class A Ordinary Shares (RPRX) creators is up XXXXX% from the previous month.
  • Royalty Pharma plc Class A Ordinary Shares (RPRX) engagements is up XXXXXX% from the previous week.
  • Royalty Pharma plc Class A Ordinary Shares (RPRX) mentions is up XXXXX% from the previous month.
  • Royalty Pharma plc Class A Ordinary Shares (RPRX) posts created is up XXXXX% from the previous week.
  • Royalty Pharma plc Class A Ordinary Shares Price hit a 52-Week high of $XXXXX for the hour

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is near a 52-week high, supported by positive market sentiment, recent dealmaking such as the acquisition of a royalty interest in Alnylam's AMVUTTRA, strong Q3 performance, and strategic buybacks, indicating a bullish trend.

24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: -XXXX%

1-Year High: $XXXXX on 2025-12-10
1-Year Low: $XXXXX on 2024-12-19

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Royalty Pharma plc Class A Ordinary Shares (RPRX) is currently AltRank #1,399 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX -XXX
X Month: XXXXX +22
X Months: XXXXX +1,111
X Year: XXXXX +57
1-Year High: XXXXX on 2025-08-11
1-Year Low: XX on 2024-12-21

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -XX
X Year: XX +6
1-Year High: XX on 2025-01-10
1-Year Low: X on 2025-11-25

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +254%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +26%
1-Year High: XXXXXXX on 2025-02-11
1-Year Low: XX on 2025-09-27

Engagements by network (24h): Reddit: XX X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +29%
X Month: XXX +37%
X Months: XXXXX +25%
X Year: XXXXX +57%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-29

Mentions by network (24h): Reddit: XX X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Royalty Pharma plc Class A Ordinary Shares (RPRX) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX +17%
X Month: XXX +35%
X Months: XXXXX +91%
X Year: XXXXX +93%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-29

The most influential creators that mention Royalty Pharma plc Class A Ordinary Shares in the last XX hours

Creator Rank Followers Posts Engagements
@MarketCap_Live X XXX X XXX
@PrismMarketView X XXXXX X XX
@Tautilas X XXXXX X XX
@AponiaAnalytics X XXXXX X XX
@foter468560 X X X XX
@MarcJacksonLA X XXXXX X X
@Trade_market8 X XX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% +35%
X Year: XXX% +20%
1-Year High: XXX% on 2025-03-16
1-Year Low: XX% on 2025-09-15

Most Supportive Themes:

  • Royalty Pharma's Financial Performance and Strategy: (30%) Discussions highlight Royalty Pharma's financial guidance, including expected shareholder returns and cash flow, alongside its strategic approach to acquiring biopharmaceutical royalties.
  • Biopharmaceutical Investments and Partnerships: (25%) Posts frequently mention Royalty Pharma's involvement in funding and acquiring stakes in biopharmaceutical companies and their drug royalties, indicating strategic partnerships and investment potential.
  • Stock Performance and Valuations: (20%) Analysis of Royalty Pharma's stock performance, including price targets, and comparisons to other healthcare stocks, suggests a focus on its investment value.

Most Critical Themes:

  • Valuation Comparisons and Market Sentiment: (15%) Some posts compare Royalty Pharma's valuation multiples to other sectors, suggesting potential overvaluation or a need for further justification of its current market position.
  • Insider Trading and Ownership Changes: (10%) Mentions of insider trading activity, including CEO stock purchases and past ownership by notable investors, prompt scrutiny and analysis of the company's internal confidence and strategic direction.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% +0.003%
X Month: XXXX% +0.016%
X Months: XXXX% +0.01%
X Year: XXXX% +0.01%
1-Year High: XXXXX% on 2025-01-25
1-Year Low: XXXXXX% on 2025-09-29

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2024-12-13

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$3.60%
X Month: $XXXXXXXXXXXXXX -$1.20%
X Months: $XXXXXXXXXXXXXX +$9.50%
X Year: $XXXXXXXXXXXXXX +$41%
1-Year High: $XXXXXXXXXXXXXX on 2025-03-16
1-Year Low: $XXXXXXXXXXXXXX on 2024-12-19

Top Royalty Pharma plc Class A Ordinary Shares Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Buy Signal Royalty Pharma plc - X Dec 2025 @ 11:51 - USD38.30"
Reddit Link @jvc72 2025-12-09T17:01Z X followers, X engagements

"After Hours Largecaps ($20-200B) - Dec X Gainers Losers $ARES +7% $ALAB -XXX% $RPRX +3.4% $INSM -XXX% $CIEN +2.1% $CHKP -XXX% $CYBR +2% $STM -XXXX% $STLD +1.7% $IMO -XXXX% $RKLB +1.3% $MRVL -XXXX% $COHR +1.3% $RDDT -XXXX% $STX +0.91% $ERIC -XXXX% $SONY +0.8% $GILD -XXX% $SMCI +0.79% $SOFI -XXXX% $BHP +0.79% $CRWV -XXXX% $HCA +0.77% $VOD -XXXX% $INTC +0.69% $MCHP -XXXX% $CCI +0.69% $STZ -XXXX% $FLEX +0.68% $ORLY -0.44%"
X Link @MarketCap_Live 2025-12-09T00:26Z XXX followers, XXX engagements

"🚀 Boost4 : Running Trades December X 🚀 XX trades open 🔥 Top performers: 🟩 $AAPL : +7.74% steady but not accelerating 🟩 $MMM : +1.75% constructive but shallow 🟩 $RPRX : +2.11% stabilizing ⚠ Weak spots: None this week. 🕓 On Hold: $UPBD mis-entered SL caused large cumulative loss; awaiting re-entry conditions $TMDX wide planned SL hit during volatility; structure still unstable New this week: $ASML $KTOS $LC $MRVL $NU $JETS 📌 Several setups finally triggered late in the week a constructive sign after prolonged market indecision. #Boost4 #TradeUpdate #TechnicalAnalysisX #Boost4"
X Link @AdiPlaut 2025-12-08T16:47Z XXX followers, XX engagements

"Its not often I own a heavily shorted healthcare company also owned by $NVDA and Cathie Wood but when I do its $rprx"
X Link @Aureliusltd28 2025-12-08T14:15Z 12.8K followers, 3950 engagements

Royalty Pharma plc Class A Ordinary Shares (RPRX)
/topic/$rprx